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ABSTRACT The thylakoid membrane, located inside the chloroplast, requires proteins transported across it for plastid bio-
genesis and functional photosynthetic electron transport. The chloroplast Tat translocator found on thylakoids transports proteins
from theplastid stroma to the thylakoid lumen.Previous studieshave shown that the chloroplast Tat pathway is independent ofNTP
hydrolysis as an energy source and instead depends on the thylakoid transmembrane proton gradient to power protein
translocation. Because of its localization on the samemembrane as the protonmotive force–dependent F0F1ATPase,we believed
that the chloroplast Tat pathway also made use of the thylakoid electric potential for transporting substrates. By adjusting the rate
of photosynthetic proton pumping and by utilizing ionophores, we show that the chloroplast Tat pathway can also utilize the
transmembrane electric potential for protein transport. Our ﬁndings indicate that the chloroplast Tat pathway is likely dependent on
the total protonmotive force (PMF) as an energy source. As a protonmotive-dependent device, certain predictions can be made
about structural features expected to be found in the Tat translocon, speciﬁcally, the presence of a proton well, a device in the
membrane that converts electrical potential into chemical potential.
INTRODUCTION
The twin arginine protein translocation (Tat, or in chloro-
plasts, cpTat) pathway derives its name from a nearly invariant
Arg-Argmotif found in the signal peptides of substrates for this
pathway (1). The Tat pathway, originally discovered in plants
(2–6) and subsequently found in prokaryotes and archaea (7),
has a number of unusual properties. In both thylakoids and
bacteria it transports fully folded proteins across themembrane
in an NTP-independent manner (3,4,8–11). The Tat transport
process has been shown in thylakoids to not compromise
the ionic integrity of the bilayer (12).A recent investigation into
the expenditure of Gibbs free energy for the transport of a
cpTat substrate concluded that the energetic cost to transport
the protein was greater than that to synthesize it (13). The
mechanism underlying transport on the Tat pathway in both
chloroplasts and bacteria is currently unknown.
A large body of work concerning the cpTat pathway has
shown that transport is dependent solely on the thylakoid trans-
membrane pH gradient (DpH) as an energy source (3,4,14),
although this has been disputed by two recent publications
concerning cpTat transport in vivo (15–17). A long-standing
unanswered question with signiﬁcant mechanistic ramiﬁca-
tions iswhether a transmembrane electric potential (Dc),which
in addition to the DpH comprises the total protonmotive force
(PMF), can contribute to the transport driving force. Previous
attempts to demonstrate such an effect with the electrogenic
ionophore valinomycin have not been successful (3,4). This is
not necessarily surprising given the observation, seemingly not
well known, that under some circumstances the Dc in isolated
thylakoids can develop in the presence of valinomycin under
steady-state illumination (18,19).
It is thought that isolated thylakoids generally partition
most of their steady-state PMF as aDpHwith only a moderate
contribution from the Dc (20). To test the hypothesis that
the Dc could contribute to the energetic driving force for
cpTat protein transport, we sought to establish conditions
under which themembrane potential would constitute a larger
proportion of the total PMF than previous experiments had
allowed. We reasoned that if the DpH established by pho-
tosynthetic electron transport decreased without similarly
affecting the membrane potential, then the remaining steady-
state PMF would be carried increasingly by the Dc. Under
such conditions, provided that the Dc contributed to the
driving force for cpTat transport, the collapse of the Dc by
valinomycin would be expected to alter the rate of protein
transport.
We show in this study that by manipulating the thylakoid
PMF either by attenuating the rate of photosynthetic proton
pumping or by the addition of ionophores, we can demon-
strate a dependence on Dc as a driving force for transport on
the cpTat pathway. Our experiments not only have ramiﬁ-
cations for the mechanism of cpTat protein transport but
point to a resolution of the question of whether the energetics
of this pathway is different in vivo and in vitro.
MATERIALS AND METHODS
Isolated thylakoids were prepared from 9- to 12-day-old peas (Pisum
sativum var. Little Marvels) as described previously (13). Thylakoids were
stored on ice in a buffer consisting of 50 mMK1-Tricine at pH 8.0, 330 mM
sorbitol, and 5 mM MgCl2, which also served as the protein transport
reaction buffer.
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The cpTat substrate used in all experiments was maize [35S]iOE17, which
was prepared by in vitro transcription and translation in rabbit reticulocyte
lysate from a cDNA clone as described (13).
In the experiment of Fig. 1, samples contained 2 ml of in vitro translated
iOE17, 20 mMmethyl viologen as a terminal electron acceptor, thylakoids at
20 mg chlorophyll and, depending on the treatment, 1 mM valinomycin, 300
nM nigericin, or 1 ml of ethanol as a loading control; the remaining reaction
volume was brought to 60 ml with reaction buffer. Protein translocation was
initiated by placing the samples in heat-ﬁltered white light (45 mE/m2s) for
6 min, a period of time determined to be within the linear regime of protein
transport (data not shown). Reactions were stopped by diluting the samples
10-fold with ice-cold reaction buffer and centrifuging in a microfuge for
5 min to pellet the thylakoids. Protein transport was determined by SDS-
PAGE and subsequent phosphor screen autoradiography and is reported as
percentage transport of substrate protein added.
Protein transport in the experiments of Figs. 2–4 was measured at a lower
chlorophyll concentration and larger volume to permit simultaneous spec-
troscopic determination of thylakoid energetic parameters. For measure-
ments of the transmembrane DpH by 9-aminoacridine (9-AA) ﬂuorescence
quenching (21), reactions contained thylakoids at 20 mg chlorophyll, 20 mM
methyl viologen, 20 mM 9-AA (lex ¼ 420, lem ¼ 480), 2 ml of in vitro
translated iOE17, and, depending on the treatment, 1 mM valinomycin
and 1 ml of ethanol as a loading control. Nigericin was added to achieve
concentrations between 0.2 nM and 6 nM in a 1 ml load to titrate the
chemical potential. The total reaction volume was brought to 500 ml with
reaction buffer. During the light titration experiments, the actinic beam was
attenuated by neutral density ﬁlters. The DpH was calculated as previously
discussed (13,21). The reaction took place in a stirred cuvette over which a
mild air current was blown to cycle O2 into the reaction mixture. Reactions
were stopped by diluting the samples twofold with ice-cold reaction buffer
and immediately centrifuging in a microfuge for 5 min to pellet the
thylakoids. The extent of protein transport was determined by SDS-PAGE
and subsequent phosphor screen autoradiography.
The electric potential–indicating electrochromic absorbance shift of carot-
enoids in the thylakoid membrane (ECS) was determined using a NoFOSpec
instrument described previously (22). The data shown are the averages of
three or four repetitions of signal-averaged (n¼ 4) ECS measurements. Each
individual sample contained thylakoids at 40 mg chlorophyll/ml, 20 mM
methyl viologen, reaction buffer to 500 ml, and, depending on the treatment,
1 mM valinomycin, nigericin between 0.3 and 15 nM, and ethanol as a
loading control. The nigericin concentrations and actinic intensities used
to determine the ECS were veriﬁed to achieve similar values of DpH as in
the protein transport experiments by 9-AA ﬂuorescence quenching.
RESULTS
To test the hypothesis that we could diminish the thylakoid
DpH without similarly affecting the Dc, the transport of
iOE17, a well-characterized cpTat substrate, was probed
under conditions of high and low inferred values of DpH, the
latter parameter adjusted by application of the nonelectro-
genic protonophore nigericin (Fig. 1). Shown are the poly-
acrylamide gels of nine replicate imports for each ionophore
treatment (Fig. 1 A). The bands labeled mOE17 that cor-
respond to translocated and N-terminally processed cpTat
substrate were quantiﬁed by densitometry based on the 10%
load standards. In the graph representing the average and
standard error of each treatment (Fig. 1 B), it can be seen that
in the absence of nigericin, a modest reduction in the protein
transport rate was affected by valinomycin, but the change
was not statistically signiﬁcant (two-tailed t-test, P ¼ 0.4).
However, in the presence of a nonsaturating concentration of
nigericin (300 nM), valinomycin reduced the rate of cpTat
transport by a level that was clearly statistically signiﬁcant
(two-tailed t-test, P , 0.01). That valinomycin has an effect
on cpTat pathway transport indicates that the electric potential
can contribute to the driving force for the cpTat transport
process.
In the experiment described above, the changes in both
DpH and Dc were inferred on the basis of addition of iono-
phores. To provide more quantitative support for the idea
that the electric potential can contribute to the driving force
FIGURE 1 Valinomycin decreases the rate of cpTat transport at low
values of DpH. (A) The import data of four ionophore treatments replicated
nine times are shown, as well as triplicates of 10% substrate loading
standards used for quantiﬁcation purposes interspersed with a nonradioac-
tive molecular weight marker (empty lanes). The average percentage
transport of each treatment as well as the standard errors and t-tests are
presented graphically (B). The two pairs of columns labeled Control and
Nigericin show the percentage transport of iOE17 Tat substrate under high-
light conditions in the absence and presence of 300 nM of nigericin. Light
shaded bars are untreated reactions, and solid bars are reactions that contain
1 mM valinomycin.
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for cpTat transport, we monitored the magnitude of the
steady-state Dc in isolated thylakoids. Carotenoids, acces-
sory pigments located in the thylakoid membrane, exhibit an
ECS that is linearly related to the transmembrane electric
potential (23,24). We sought to measure the steady-state
ECS of thylakoids during 1 min of actinic illumination under
conditions designed to attenuate the different components of
the PMF (Fig. 2). We ﬁrst determined the response of the
ECS signal when the actinic intensity was constant and the
passive proton ﬂux through the thylakoid membrane was
increased by the addition of increasing nigericin concentra-
tions (Fig. 2 A). Nigericin addition alone actually promoted
an increase of the Dc, likely as a result of decreased proton
backpressure or photosynthetic control on electron transport
(25). Under the same conditions, but with 1 mM valinomycin
present in the reaction, the steady-state electric potential was
dissipated with increasing nigericin concentrations. It can be
seen (Fig. 2 B) that the ECS does not appreciably decrease
when the actinic light is limited (shaded bars). The reduction
of the ECS by the inclusion of 1 mM valinomycin (solid
bars) in the reaction medium is imperceptible at high actinic
intensities but increases as actinic light is limited.
Component ECS traces are shown to illustrate the electric
potential changes we observed (Fig. 2, C–F). The steady-
state levels of the ECS traces were used to plot the bar graphs
above the traces (Fig. 2, A and B). In each paired trace, the
reaction run without valinomycin exhibits a spike of electric
potential occurring at the onset of actinic illumination; the
reactions exhibiting a slower initial rate of electric potential
change are those run with valinomycin. The characteristic
thylakoid electric potential spike at the onset of actinic
illumination is present at high-light conditions (Fig. 2, C–E),
but with lower-actinic-intensity illumination, the spike is
subdued even though the ECS signal still develops rapidly
(Fig. 2 F). In every case, valinomycin has the effect of
muting the initial electric potential spike. However, when the
actinic intensity is low (Fig. 2 F), or there is additional
potassium ion ﬂux into the membrane via nigericin (Fig. 2 D),
valinomycin also depresses the total electric potential that the
thylakoids are able to develop compared to high-light controls
(Fig. 2, C and E, respectively).
With the information from Fig. 2 concerning the response
of the thylakoid electric potential to the presence of valino-
mycin under changing PMF conditions brought about either
by nigericin addition or by actinic light intensity attenuation,
protein transport experiments were designed to determine
semiquantitatively the dependence of the cpTat pathway on
Dc as a function of DpH. To guide our experimental design,
we constructed models of response of the thylakoid steady-
state PMF to changes in actinic light intensity or to nigericin
titrations (Fig. 3, insets). Because nigericin titration resulted
in an increase in the steady-state electric potential, whereas
actinic light intensity attenuation had no effect on this pa-
rameter, we modeled the thylakoid Dc response to those
titrants as rising and level, respectively. Because the addition
of valinomycin dissipates the steady-state electric potential
both at low actinic intensity and at high nigericin concentra-
tions (as demonstrated in Fig. 2), both of which result in a
reduction of the total PMF driving force, we predicted that the
greatest effect of valinomycin on protein transport would be
observed under these conditions.
In Fig. 3, we show the results of cpTat protein transport
experiments carried out using 6 min of actinic illumination
and in which the DpH was decreased by two different
methods. In the ﬁrst, the DpH was controlled by including
nigericin, which increases the passive proton permeability of
the membrane (as in the experiment of Fig. 1) and, coupled
to reduced feedback on photosynthetic electron transport,
FIGURE 2 ECS of carotenoids indicates the electric
potential in thylakoids. The ECS values presented are the
deﬂection of carotenoid absorbance from a dark baseline to a
steady-state level achieved during a 1-min actinic illumina-
tion period. (A) Effect of valinomycin when the DpH was
lowered using increasing nigericin concentrations. (B) Effect
of valinomycinwhen theDpHwas lowered using decreasing
actinic light intensities. In bothpanels the twopaired columns
represent the ECS in the absence (solid bars) or presence
(light shaded bars) of 1mMvalinomycin. The standard error
is basedon three to four replicatesof fourfold signal-averaged
ECS measurements. (C–F) Selected paired traces of ECS
measurements of which the steady state magnitude was used
in creating the above graphs. Of the paired traces, in all cases,
the steady-state electric potential–indicating ECS signal that
developed without a rapid spike of electrochromism at the
onset of illumination was the treatment containing 1 mM
valinomycin. (C, D) The two paired ECS traces were each
performed at an actinic intensity of 20 mE s1m2, but (C)
without nigericin and (D) with 1.5 nM nigericin. (E, F) The
two pairedECS traces consist of experiments performedwith
actinic light intensities of 20 and 10 mE s1m2, respec-
tively.
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causes an increase in Dc (Fig. 2 A). Under these conditions
valinomycin addition had a clear impact on the protein
transport rate (Fig. 3 A). This experiment demonstrates that
valinomycin has an unmistakable effect on cpTat protein
transport when measured under conditions in which the electric
potential constitutes a signiﬁcant portion of the total PMF.When
the secondmethodwas used, theDpHwas controlled by altering
the light intensity used to drive the photosynthetic electron
transport chain, which affects the rate of proton deposition into
the thylakoid lumen (Fig. 3B). Contrary to our expectations, the
rate of translocation of iOE17 into the thylakoid lumen was not
affected by the addition of valinomycin.
We considered that the ECS signal at 1 min, as determined
in Fig. 2, may not be an accurate reﬂection of the Dc during
the 6-min protein transport experiment reported in Fig. 3. In
an attempt to reconcile our Dc measurements with protein
transport data, we decreased the duration of the cpTat transport
experiments to 1 min. Fig. 4 shows that in the presence of
100 nMnigericin and at low actinic light intensity, valinomycin
effected a signiﬁcant decrease in cpTat transport during a 1-min
experiment, even though theDpHwas approximately the same
for both samples (compare circle and square at the same
abscissa value in Fig. 4 A). This conﬁrms our previous results
seen in Figs. 1 and 3 A and indicates that the thylakoid Dc can
contribute to the driving force for cpTat transport.
Under identical low-actinic-illumination conditions, but
without nigericin (Fig. 4 B), valinomycin addition (square)
resulted in a similar rate of protein transport compared to the
control (circle). However, valinomycin had the effect of in-
creasing the DpH across the thylakoid membrane. This result
suggests that valinomycin caused an increase in the rate of
proton pumping by relieving the electrical backpressure
on the electron transport chain, an observation that to our
knowledge has not been reported before. We can expect that
the decrease in Dc by valinomycin addition was approxi-
mately energetically equivalent to the increase inDpH.When
the intensity of actinic illumination was adjusted so that the
valinomycin-treated samples maintained a DpH roughly
similar to that of the control samples (triangle), a decrease in
import by valinomycin was apparent (two-tailed t-test, n¼ 6,
P, 0.01). This demonstrates that, in addition to its effect on
the cpTat pathway when the PMF is controlled by nigericin,
valinomycin also affects the rate of protein transport under
conditions in which the PMF is controlled by the light-
dependent photosynthetic proton pumping rate, a result not
apparent in our earlier 6-min experiment (Fig. 3 B).
DISCUSSION
The data reported in this communication demonstrate that,
in addition to the DpH established across the thylakoid
membrane in the light, the transmembrane Dc can also
contribute to the energetics of protein transport on the cpTat
pathway. We suspect that one reason this was not previously
detected is that the prior transport assays were carried out at
high light intensities for relatively long periods of time.
These conditions would make electric potential effects dif-
ﬁcult to observe for two possible reasons. First, when the
photosynthetic electron transport chain is operating at the
higher end of its capacity, the steady-state electric potential
across the thylakoid membrane contributes a relatively small
proportion of the total thylakoid PMF. Under these condi-
tions, loss of the electric potential on valinomycin addition
would affect cpTat transport subtly and could be overlooked.
Second, the effect of valinomycin addition on thylakoid
electric potential during long periods of actinic illumination
FIGURE 3 Protein transport as a function of DpH
attenuated with nigericin (A) or actinic light intensity (B).
Protein transport is plotted against DpH determined by
9-AA ﬂuorescence quenching in the absence (solid circles)
or presence of 1 mMvalinomycin (light shaded diamonds).
Insets represent models of the components of the PMF in a
thylakoid during a DpH titration with either nigericin (A) or
actinic intensity (B). Solid lines represent the total PMF,
which is the sum of the DpH and the Dc; dashed lines
represent the Dc; dot-dashed line represents the DpH; solid
and light shaded lines represent titrations in the presence or
absence of valinomycin, respectively.
FIGURE 4 Protein transport during a 1-min reaction is affected byDcwhen
theDpHis titratedwith light. The attenuated thylakoidDpHwas set bynigericin
addition (A) or by lowactinic light intensity (B).Averages and standard errors of
six replicate treatments are shownwithout (solid circles) andwith (light shaded
squares) 1mMvalinomycin, respectively, in otherwise identical conditions and
(B) at a lower light intensity to reset the DpH in the presence of 1 mM
valinomycin (light shaded triangle) to that without valinomycin.
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is different from the effect known for short illumination pe-
riods. At the onset of actinic illumination, the valinomycin-
induced rate of potassium ﬂux across the membrane is
sufﬁciently high to quickly dissipate the electric potential
caused by charge separation in the reaction centers or by initial
proton pumping by the electron transport chain. However, as
light-driven proton ﬂux into the thylakoid lumen continues, the
rate of valinomycin-dependent potassium efﬂux decreases, as
is evidenced by the buildup of the electric potential (Fig. 2).
This reduction in valinomycin activity is likely caused by
depletion of potassium ions from the ﬁnite volume of the
thylakoid lumen.By using 10ml/mg chlorophyll as an estimate
of the thylakoid lumen volume (26) and by assuming that
potassium is equilibrated across themembrane in dark-adapted
thylakoids, that most internal potassium is not bound, and that
proton pumping occurs at a modest rate of 120 mmol per mg
chlorophyll per hour, one can calculate that the potassium store
of the lumen could be depleted by electrogenic compensation
for proton pumping within seconds after the onset of illumi-
nation. Thus, under continuous illumination, the potassium
ion gradient established by valinomycin would approach the
Nernst equilibrium set by the electric potential resulting
from light-dependent proton pumping. In contrast to this, the
electric potential was diminished under all light regimes when
valinomycin was applied in conjugation with nigericin, a
H1/K1 antiporter, which would serve to replenish the lumen
potassium concentration during proton gradient dissipation.
Valinomycin seems to have a similar effect on the rate of
development of electric potential as does low actinic intensity.
Comparing theECS trace obtained in high light in the presence of
valinomycin (Fig. 2 E, lower trace) to that in a low light control
(Fig. 2F,upper trace), it can be seen that neither condition allows
for the electric potential to develop as rapidly as in high-light
conditions in theabsenceof electrogenic ionophores (Fig. 2,C–E,
upper traces). The similarity between the traces obtained under
those two conditions must result from comparable ratios of
electric potential accumulation and dissipation, even though the
absolute ion ﬂux rates in the two cases should be quite different.
The dual energy utilization of the cpTat pathway suggests
that it is likely a PMF-utilizing device, as are the reversible
H1-ATPases located on the thylakoid and other energy-
transducing membranes. If true, then protein transport studies
such as this one may also lead to information pertaining to
thylakoid energetics. For instance, the difference in cpTat
transport between valinomycin-treated and control samples as
a function ofDpH (expressed inmV) could be used as ameans
to estimate in vitro themagnitude of theDc under steady-state
illumination and to calibrate the ECS signal. Speciﬁcally, the
data in Fig. 4 B show that valinomycin caused an increase in
theDpHof;0.5 unitswithout signiﬁcantly changing the driv-
ing force for iOE17 transport (the PMF), which suggests that
the original steady-state Dc was ;30 mV under the con-
ditions of that experiment.
Our ﬁndings bear directly on the question of whether the
energetics of cpTat protein transport are different in vitro and
in vivo (15–17). In the ﬁrst of the studies leading to this
suggestion, mutants of Chlamydomonas reinhardtii that are
unable to generate a pHgradientwere seen to accumulate cpTat
substrates in the thylakoid lumen. However, these algae were
able to generate a light-induced electric ﬁeld (27), and our
ﬁnding that the Dc can contribute to the energetics of cpTat
protein transport explainshow theywere able to transport cpTat
substrates. The second study questioning whether the DpH is
the driving force for cpTat protein transport utilized tobacco
protoplasts poisoned with ionophores to dissipate the PMF.
However, the Dc was not measured in these experiments,
andwe show inFig. 2 that an electric ﬁeld is in fact generated in
the presence of valinomycin during continuous illumination,
an observation that has been made previously (18,19). The
existence of a small PMF in those experiments, even in the
presence of nigericin and valinomycin, is inferred from
the ability of the cells to carry out limited protein synthesis, a
process depending on ATP generation. Thus, we believe our
experiments demonstrate that a driving force for cpTat trans-
port was available in all the experiments in these two studies
and that there is no need to invoke a different energetics for this
pathway in vitro and in vivo (17).
It has long been recognized that although the DpH and Dc
are thermodynamically equivalent, they are not mechanisti-
cally equivalent, and thus, work obtained from each energy
source need not lead to the same rates of a given chemiosmotic
reaction. In response to this, Mitchell proposed that the H1-
ATPases operate via a proton well wherein the electric
potential is converted into a DpH within the membrane and
that the real chemical work is performed only by the latter
(28). Such a proton well is realized in the structure of the F0/
CF0/EF0 portions of the H
1-ATPases in which protons have
an unrestricted path through the F0 subunit for travel from the
p to the n side of the membrane before encountering the F1
subunit (29,30). Our ﬁnding that the cpTat translocon is likely
a PMF-utilizing device leads to a similar prediction: that its
structure will also contain a pathway allowing free passage of
protons into the membrane, wherein the electric potential
will be converted to a local pH gradient within the translocon.
The positive net charge on the Tat–directing signal peptides
and the basic nature of some cpTat passenger proteins would
appear to rule out electrophoresis as a transport driving force,
making the thermodynamically equivalent proton trap (which
converts the DpH into a Dc (28)) a less likely alternative.
Experiments designed to detect the presence of such a proton
well in the cpTat translocon are currently under way.
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